Therapeutic targeting of non-coding RNAs in cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389013%3A_____%2F17%3A00483455" target="_blank" >RIV/61389013:_____/17:00483455 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14740/17:00100445 RIV/00209805:_____/17:00077864
Result on the web
<a href="http://dx.doi.org/10.1042/BCJ20170079" target="_blank" >http://dx.doi.org/10.1042/BCJ20170079</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1042/BCJ20170079" target="_blank" >10.1042/BCJ20170079</a>
Alternative languages
Result language
angličtina
Original language name
Therapeutic targeting of non-coding RNAs in cancer
Original language description
The majority of the human genome encodes RNAs that do not code for proteins. These non-coding RNAs (ncRNAs) affect normal expression of the genes, including oncogenes and tumour suppressive genes, which make them a new class of targets for drug development in cancer. Although microRNAs (miRNAs) are the most studied regulatory ncRNAs to date, and miRNA-targeted therapeutics have already reached clinical development, including the mimics of the tumour suppressive miRNAs miR-34 and miR-16, which reached phase I clinical trials for the treatment of liver cancer and mesothelioma, the importance of long non-coding RNAs (lncRNAs) is increasingly being recognised. Here, we describe obstacles and advances in the development of ncRNA therapeutics and provide the comprehensive overview of the ncRNA chemistry and delivery technologies. Furthermore, we summarise recent knowledge on the biological functions of miRNAs and their involvement in carcinogenesis, and discuss the strategies of their therapeutic manipulation in cancer. We review also the emerging insights into the role of lncRNAs and their potential as targets for novel treatment paradigms. Finally, we provide the up-to-date summary of clinical trials involving miRNAs and future directions in the development of ncRNA therapeutics.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10609 - Biochemical research methods
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biochemical Journal
ISSN
0264-6021
e-ISSN
—
Volume of the periodical
474
Issue of the periodical within the volume
24
Country of publishing house
GB - UNITED KINGDOM
Number of pages
33
Pages from-to
4219-4251
UT code for WoS article
000423617100004
EID of the result in the Scopus database
2-s2.0-85039561689